Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
MDGL
Stock Latest News
The Fly
Short Report: Vera Therapeutics bears retreat as stock rallies
23h ago
MBLY
MDGL
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $900 from $540 at Piper Sandler
3d ago
MDGL
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $581 from $456 at BofA
6d ago
MDGL
Premium
Ratings
Cautious Outlook for Madrigal Pharmaceuticals Amid Competitive Pressures and Adoption Challenges
6d ago
MDGL
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $670 from $560 at B. Riley
11d ago
MDGL
Premium
Market News
CRNX, CYTK, MDGL, SLNO: Top Analyst Outlines Her ‘Top Biotech Ideas for 2026’
14d ago
CRNX
CYTK
Premium
Ratings
Strong Adoption and Market Expansion Drive Buy Rating for Madrigal Pharmaceuticals’ Rezdiffra
1M ago
MDGL
Premium
The Fly
Madrigal price target raised to $620 from $568 at H.C. Wainwright
1M ago
MDGL
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $650 from $600 at Oppenheimer
1M ago
MDGL
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $640 from $580 at Truist
1M ago
MDGL
Premium
The Fly
Paulson exits Iamgold, boosts Bausch Health in Q3
1M ago
SA
Premium
Ratings
Optimistic Buy Rating for Madrigal Pharmaceuticals Driven by Strong Drug Performance and Strategic European Expansion
1M ago
MDGL
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $587 from $526 at Canaccord
1M ago
MDGL
Premium
The Fly
Madrigal price target raised to $568 from $500 at H.C. Wainwright
1M ago
MDGL
Premium
The Fly
Madrigal Pharmaceuticals presents new data on Rezdiffra
1M ago
MDGL
Premium
Company Announcements
Madrigal’s Earnings Call: Rezdiffra’s Success and Future Outlook
2M ago
MDGL
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $527 from $485 at Citizens JMP
2M ago
MDGL
Premium
Company Announcements
Madrigal Pharmaceuticals Reports Strong Q3 2025 Growth
2M ago
MDGL
Premium
Ratings
Madrigal Pharmaceuticals: Strong Market Performance and Strategic Positioning Drive Buy Rating
2M ago
MDGL
Premium
The Fly
Cantor upgrades Madrigal to Overweight on 2026 growth potential
2M ago
MDGL
Premium
The Fly
Madrigal Pharmaceuticals upgraded to Overweight from Neutral at Cantor Fitzgerald
2M ago
MDGL
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $533 from $431 at Clear Street
2M ago
MDGL
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
